Healthcare stocks were steady pre-bell Friday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) down a slight 0.1%.
Grifols (GRFS) stock was up more than 2% after the company posted a higher Q1 adjusted profit.
ANI Pharmaceuticals (ANIP) shares were up more than 4% after the company reported higher Q1 adjusted earnings and net revenue, and raised its 2026 outlook.
Artiva Biotherapeutics (ARTV) stock was up more than 3% after the company priced its $300 million underwritten offering of common shares and pre-funded warrants.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments